Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

28 mai 2026 08h05 HE | Source: Totaligent

Totaligent Announces Formation of Joint Venture with GloMed Solutions to Commercialize Advanced Biologics in Japan and APAC

Totaligent (OTCID: TGNT) forms JV with GloMed Solutions, a Japanese company with a proven distribution network in the Asia-Pacific region.
29 avr. 2026 09h20 HE | Source: 24/7 Market News and Totaligent

FDA’s AI Push Ignites a new Biotech Arms Race and Totaligent may be quietly Positioning Itself at the Center

The FDA is making AI part of the R&D core infrastructure and companies like Totaligent (OTCID: TGNT) are building the “picks-and-shovels” layer of biotech
12 févr. 2026 09h00 HE | Source: Totaligent

Totaligent Executes Binding LOI for Strategic Acqui-hire of Aetherium Medical Team, Intellectual Property, and Platform Assets

Totaligent (OTCID: TGNT) executed a binding LOI for the acqui-hire of Aetherium Medical (https://www.aetheriummedical.com/)